Year |
Citation |
Score |
2023 |
Stachulski AV, Rossignol JF, Pate S, Taujanskas J, Iggo JA, Aerts R, Pascal E, Piacentini S, La Frazia S, Santoro MG, van Vooren L, Sintubin L, Cooper M, Swift K, O'Neill PM. Thiazolide Prodrug Esters and Derived Peptides: Synthesis and Activity. Acs Bio & Med Chem Au. 3: 327-334. PMID 37599793 DOI: 10.1021/acsbiomedchemau.2c00083 |
0.462 |
|
2021 |
Stachulski AV, Rossignol JF, Pate S, Taujanskas J, Robertson CM, Aerts R, Pascal E, Piacentini S, Frazia S, Santoro MG, O'Neill PM. Synthesis, antiviral activity, preliminary pharmacokinetics and structural parameters of thiazolide amine salts. Future Medicinal Chemistry. PMID 34402654 DOI: 10.4155/fmc-2021-0055 |
0.494 |
|
2021 |
Rolt A, Talley DC, Park SB, Hu Z, Dulcey A, Ma C, Irvin P, Leek M, Wang AQ, Stachulski AV, Xu X, Southall N, Ferrer M, Liang TJ, Marugan JJ. Discovery and Optimization of a 4-Aminopiperidine Scaffold for Inhibition of Hepatitis C Virus Assembly. Journal of Medicinal Chemistry. PMID 34184537 DOI: 10.1021/acs.jmedchem.1c00696 |
0.648 |
|
2020 |
Stachulski AV, Taujanskas J, Pate SL, Rajoli RKR, Aljayyoussi G, Pennington SH, Ward SA, Hong WD, Biagini GA, Owen A, Nixon GL, Leung SC, O'Neill PM. Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2? Acs Infectious Diseases. PMID 33352056 DOI: 10.1021/acsinfecdis.0c00478 |
0.502 |
|
2019 |
Rolt A, O'Neill PM, Liang TJ, Stachulski AV. Synthesis of MeBmt and related derivatives syn-selective ATH-DKR. Rsc Advances. 9: 40336-40339. PMID 32864110 DOI: 10.1039/C9Ra08256E |
0.64 |
|
2019 |
Rolt A, O'Neill PM, Liang TJ, Stachulski AV. Synthesis of MeBmt and related derivatives via syn-selective ATH-DKR Rsc Advances. 9: 40336-40339. DOI: 10.1039/c9ra08256e |
0.421 |
|
2018 |
Stachulski AV, Santoro MG, Piacentini S, Belardo G, Frazia S, Pidathala C, Row EC, Berry NG, Iqbal M, Allman SA, Semple JE, Eklov BM, O'Neill PM, Rossignol JF. Second-generation nitazoxanide derivatives: thiazolides are effective inhibitors of the influenza A virus. Future Medicinal Chemistry. PMID 29629834 DOI: 10.4155/Fmc-2017-0217 |
0.438 |
|
2017 |
Hong WD, Gibbons PD, Leung SC, Amewu R, Stocks PA, Stachulski AV, Horta PC, Cristiano ML, Shone AE, Moss D, Ardrey A, Sharma R, Warman AJ, Bedingfield PT, Fisher NE, et al. Rational Design, Synthesis and Biological Evaluation of Heterocyclic Quinolones Targeting the respiratory chain of Mycobacterium tuberculosis. Journal of Medicinal Chemistry. PMID 28304162 DOI: 10.1021/Acs.Jmedchem.6B01718 |
0.516 |
|
2013 |
Elliott EC, Maggs JL, Park BK, O'Neill PM, Stachulski AV. Convenient syntheses of halo-dibenz[b,f]azepines and carbamazepine analogues via N-arylindoles. Organic & Biomolecular Chemistry. 11: 8426-34. PMID 24193242 DOI: 10.1039/C3Ob41252K |
0.512 |
|
2011 |
Stachulski AV, Pidathala C, Row EC, Sharma R, Berry NG, Lawrenson AS, Moores SL, Iqbal M, Bentley J, Allman SA, Edwards G, Helm A, Hellier J, Korba BE, Semple JE, et al. Thiazolides as novel antiviral agents. 2. Inhibition of hepatitis C virus replication. Journal of Medicinal Chemistry. 54: 8670-80. PMID 22059983 DOI: 10.1021/jm201264t |
0.303 |
|
2011 |
Elliott EC, Bowkett ER, Maggs JL, Bacsa J, Park BK, Regan SL, O'Neill PM, Stachulski AV. Convenient syntheses of benzo-fluorinated dibenz[b,f]azepines: rearrangements of isatins, acridines, and indoles. Organic Letters. 13: 5592-5. PMID 21939196 DOI: 10.1021/Ol202318W |
0.489 |
|
2010 |
Amewu R, Gibbons P, Mukhtar A, Stachulski AV, Ward SA, Hall C, Rimmer K, Davies J, Vivas L, Bacsa J, Mercer AE, Nixon G, Stocks PA, O'Neill PM. Synthesis, in vitro and in vivo antimalarial assessment of sulfide, sulfone and vinyl amide-substituted 1,2,4-trioxanes prepared via thiol-olefin co-oxygenation (TOCO) of allylic alcohols. Organic & Biomolecular Chemistry. 8: 2068-77. PMID 20401383 DOI: 10.1039/B924319D |
0.521 |
|
2010 |
Pacorel B, Leung SC, Stachulski AV, Davies J, Vivas L, Lander H, Ward SA, Kaiser M, Brun R, O'Neill PM. Modular synthesis and in vitro and in vivo antimalarial assessment of C-10 pyrrole mannich base derivatives of artemisinin. Journal of Medicinal Chemistry. 53: 633-40. PMID 19957999 DOI: 10.1021/jm901216v |
0.556 |
|
2010 |
O'Neill PM, Miller A, Ward SA, Park BK, Scheinmann F, Stachulski AV. ChemInform Abstract: Application of the TMSOTf-AgClO4 Activator System to the Synthesis of Novel, Potent, C-10 Phenoxy Derivatives of Dihydroartemisinin. Cheminform. 31: no-no. DOI: 10.1002/CHIN.200010164 |
0.575 |
|
2006 |
Amewu R, Stachulski AV, Ward SA, Berry NG, Bray PG, Davies J, Labat G, Vivas L, O'Neill PM. Design and synthesis of orally active dispiro 1,2,4,5-tetraoxanes; synthetic antimalarials with superior activity to artemisinin. Organic & Biomolecular Chemistry. 4: 4431-6. PMID 17268634 DOI: 10.1039/B613565J |
0.518 |
|
2006 |
Amewu R, Stachulski AV, Berry NG, Ward SA, Davies J, Labat G, Rossignol JF, O'Neill PM. Synthesis of 1,2,4-trioxepanes via application of thiol-olefin co-oxygenation methodology. Bioorganic & Medicinal Chemistry Letters. 16: 6124-30. PMID 16978862 DOI: 10.1016/j.bmcl.2006.08.098 |
0.484 |
|
2006 |
Row EC, Brown SA, Stachulski AV, Lennard MS. Synthesis of 8-geranyloxypsoralen analogues and their evaluation as inhibitors of CYP3A4. Bioorganic & Medicinal Chemistry. 14: 3865-71. PMID 16481174 DOI: 10.1016/J.BMC.2006.01.046 |
0.301 |
|
2005 |
Row E, Brown SA, Stachulski AV, Lennard MS. Development of novel furanocoumarin dimers as potent and selective inhibitors of CYP3A4. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 34: 324-30. PMID 16299162 DOI: 10.1124/Dmd.105.007294 |
0.343 |
|
2005 |
Esposito M, Stettler R, Moores SL, Pidathala C, Müller N, Stachulski A, Berry NG, Rossignol JF, Hemphill A. In vitro efficacies of nitazoxanide and other thiazolides against Neospora caninum tachyzoites reveal antiparasitic activity independent of the nitro group. Antimicrobial Agents and Chemotherapy. 49: 3715-23. PMID 16127045 DOI: 10.1128/Aac.49.9.3715-3723.2005 |
0.301 |
|
2004 |
Kenny JR, Maggs JL, Meng X, Sinnott D, Clarke SE, Park BK, Stachulski AV. Syntheses and characterization of the acyl glucuronide and hydroxy metabolites of diclofenac Journal of Medicinal Chemistry. 47: 2816-2825. PMID 15139759 DOI: 10.1021/jm030891w |
0.306 |
|
2001 |
O'Neill PM, Scheinmann F, Stachulski AV, Maggs JL, Park BK. Efficient preparations of the beta-glucuronides of dihydroartemisinin and structural confirmation of the human glucuronide metabolite. Journal of Medicinal Chemistry. 44: 1467-70. PMID 11311070 DOI: 10.1021/jm001061a |
0.416 |
|
2001 |
O'Neill PM, Miller A, Bishop LP, Hindley S, Maggs JL, Ward SA, Roberts SM, Scheinmann F, Stachulski AV, Posner GH, Park BK. Synthesis, antimalarial activity, biomimetic iron(II) chemistry, and in vivo metabolism of novel, potent C-10-phenoxy derivatives of dihydroartemisinin. Journal of Medicinal Chemistry. 44: 58-68. PMID 11141088 DOI: 10.1021/jm000987f |
0.554 |
|
1999 |
O'Neill PM, Miller A, Ward SA, Park B, Scheinmann F, Stachulski AV. Application of the TMSOTfAgClO4 activator system to the synthesis of novel, potent, C-10 phenoxy derivatives of dihydroartemisinin Tetrahedron Letters. 40: 9129-9132. DOI: 10.1016/S0040-4039(99)01891-2 |
0.567 |
|
Show low-probability matches. |